$0.34
-0.22 (-39.66%)
Open$0.36
Previous Close$0.56
Day High$0.38
Day Low$0.33
52W High$19.74
52W Low$0.46
Volume—
Avg Volume985.4K
Market Cap4.56M
P/E Ratio—
EPS$-11.96
SectorBiotechnology
Analyst Ratings
Strong Buy
5 analysts
Price Target
+6,440.4% upside
Current
$0.34
$0.34
Target
$22.10
$22.10
$15.13
$22.10 avg
$31.02
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 680.6K | 796.4K | 1.31M |
| Net Income | -107,887,269 | -113,618,701 | -292,011 |
| Profit Margin | -15,861.4% | -15,068.3% | -22.2% |
| EBITDA | -93,216,883 | -103,622,792 | -341,169 |
| Free Cash Flow | — | — | -173,511 |
| Rev Growth | -14.5% | -14.5% | +20.5% |
| Debt/Equity | — | — | 0.83 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $201.55 | -0.57% | 88.1 | 372.29B |
| AMGN | Amgen Inc | $331.70 | +0.79% | 22.7 | 176.88B |
| GILD | Gilead Sciences Inc | $131.33 | -2.04% | 19.3 | 163.92B |
| VRTX | Vertex Pharmaceuticals Inc | $429.82 | +1.13% | 27.7 | 109.50B |
| REGN | Regeneron Pharmaceuticals | $714.89 | +0.82% | 16.5 | 74.30B |
| ALNY | Alnylam Pharmaceuticals Inc | $295.05 | -0.29% | 130.4 | 40.90B |